首页> 外文期刊>BMJ Open >Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales—a study protocol
【24h】

Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales—a study protocol

机译:估算英国哮喘的发病率,患病率和真实成本:研究方案对英格兰,北爱尔兰,苏格兰和威尔士的国家独立数据库和链接数据库进行二次分析

获取原文
           

摘要

Introduction Asthma is now one of the most common long-term conditions in the UK. It is therefore important to develop a comprehensive appreciation of the healthcare and societal costs in order to inform decisions on care provision and planning. We plan to build on our earlier estimates of national prevalence and costs from asthma by filling the data gaps previously identified in relation to healthcare and broadening the field of enquiry to include societal costs. This work will provide the first UK-wide estimates of the costs of asthma. In the context of asthma for the UK and its member countries (ie, England, Northern Ireland, Scotland and Wales), we seek to: (1) produce a detailed overview of estimates of incidence, prevalence and healthcare utilisation; (2) estimate health and societal costs; (3) identify any remaining information gaps and explore the feasibility of filling these and (4) provide insights into future research that has the potential to inform changes in policy leading to the provision of more cost-effective care. Methods and analysis Secondary analyses of data from national health surveys, primary care, prescribing, emergency care, hospital, mortality and administrative data sources will be undertaken to estimate prevalence, healthcare utilisation and outcomes from asthma. Data linkages and economic modelling will be undertaken in an attempt to populate data gaps and estimate costs. Separate prevalence and cost estimates will be calculated for each of the UK-member countries and these will then be aggregated to generate UK-wide estimates. Ethics and dissemination Approvals have been obtained from the NHS Scotland Information Services Division's Privacy Advisory Committee, the Secure Anonymised Information Linkage Collaboration Review System, the NHS South-East Scotland Research Ethics Service and The University of Edinburgh's Centre for Population Health Sciences Research Ethics Committee. We will produce a report for Asthma-UK, submit papers to peer-reviewed journals and construct an interactive map.
机译:简介哮喘现已成为英国最常见的长期疾病之一。因此,重要的是全面了解医疗保健和社会成本,以便为护理提供和计划的决策提供依据。我们计划通过弥补先前发现的与医疗保健相关的数据空白,并扩大调查范围以包括社会成本,从而基于我们之前对全国哮喘患病率和成本的估计。这项工作将提供全英国范围内哮喘费用的第一笔估计值。对于英国及其成员国(即英国,北爱尔兰,苏格兰和威尔士)的哮喘,我们力求:(1)详尽评估发病率,患病率和医疗保健利用; (2)估算健康和社会成本; (3)找出任何剩余的信息空白,并探讨填补这些空白的可行性,以及(4)提供对未来研究的见识,这些研究有可能为政策变化提供信息,从而提供更具成本效益的护理。方法和分析将对来自国家健康调查,初级保健,处方,急诊,医院,死亡率和行政数据来源的数据进行二次分析,以评估哮喘的患病率,医疗利用率和结局。将进行数据链接和经济建模,以试图填补数据空白并估算成本。将为每个英国成员国计算单独的患病率和成本估算,然后将其汇总以生成英国范围的估算。道德和传播批准书已从NHS苏格兰信息服务部的隐私咨询委员会,安全匿名信息链接协作审核系统,NHS东南苏格兰研究道德服务和爱丁堡大学人口健康科学研究中心伦理委员会获得。我们将为英国Asthma制作一份报告,向同行评审的期刊提交论文,并构建一个交互式地图。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号